Kevin DeJong

ID: 1b83dfec-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Trial Scheduled for April 2024 in BMS Patent Case Against AstraZeneca Regarding Anti-PDL1 Antibodies

Big Molecule Watch · May 23, 2022

Pfizer Files Lawsuit in Australia to Halt Sales of BRENZYS (etanercept)

Big Molecule Watch · May 12, 2022

Amgen Announces Positive Results for Phase 3 Study of Ustekinumab Biosimilar

Big Molecule Watch · April 22, 2022

PTAB Institutes Another IPR on a Tocilizumab Patent Challenged by Fresenius

Big Molecule Watch · March 14, 2022

PTAB Institutes Two More IPRs on Tocilizumab Patents Challenged by Fresenius

Big Molecule Watch · February 25, 2022